EUVIMEDEUVIMED entdecken
Crossref

Maternal hormonal contraceptive use and childhood central nervous system tumor risk in a large Scandinavian cohort

Caroline H Hemmingsen iD, Susanne K Kjaer iD, Sarah Hjorth iD, Ulrika Nörby iD, Anton Pottegård iD, René Mathiasen, Charlotte Wessel Skovlund, Maarit K Leinonen iD, Hedvig Nordeng iD, Lina S Mørch iD, Marie Hargreave iD

International Journal of Cancer · 2025

DOI: 10.1002/ijc.35509 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cancer, 2025. Verfasst von Caroline H Hemmingsen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Virus, Lifestyle and Genes, Danish Cancer Institute, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Central Nervous System Neoplasms, Prenatal Exposure Delayed Effects, Hormonal Contraception. Die Arbeit nennt 40 Literaturangaben. Gefördert von: Helsefonden, Nordic Cancer Union, Dagmar Marshalls Fond.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

An association between maternal hormonal contraception use and childhood central nervous system (CNS) tumors has been suggested, but findings are inconclusive. This population‐based cohort study includes Scandinavian nationwide registry data on liveborn children (1996–2018). Children were followed from birth until CNS tumor (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Central Nervous System NeoplasmsPrenatal Exposure Delayed EffectsHormonal ContraceptionHumansFemaleChildScandinavian and Nordic CountriesChild, PreschoolPregnancyCohort StudiesMaleInfantAdolescentRegistriesRisk FactorsAdultInfant, NewbornYoung AdultProportional Hazards Models

Stichwörter der Autor:innen

Scandinaviacentral nervous system tumorchildhood cancerhormonal contraceptionmedroxyprogesterone acetate

Autor:innen und Institutionen

  • Virus, Lifestyle and Genes, Danish Cancer Institute, Copenhagen, Denmark.
  • Department of Gynecology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
  • PharmacoEpidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo, Oslo, Norway.
  • Health and Medical Care Administration, Region Stockholm, Stockholm, Sweden.
  • Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark.
  • Department of Pediatrics and Adolescent Medicine, Juliane Marie Centre, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.

ORCID-Profile: Caroline H Hemmingsen, Susanne K Kjaer, Sarah Hjorth, Ulrika Nörby, Anton Pottegård, Maarit K Leinonen, Hedvig Nordeng, Lina S Mørch, Marie Hargreave

Förderung

  • Helsefonden
  • Nordic Cancer Union
  • Dagmar Marshalls Fond
  • Danmarks Frie Forskningsfond

Zitieren

APA

Hemmingsen, C. H., Kjaer, S. K., Hjorth, S., Nörby, U., Pottegård, A., Mathiasen, R., Skovlund, C. W., Leinonen, M. K., Nordeng, H., Mørch, L. S., & Hargreave, M. (2025). Maternal hormonal contraceptive use and childhood central nervous system tumor risk in a large Scandinavian cohort. International Journal of Cancer. https://doi.org/10.1002/ijc.35509

Vancouver

Hemmingsen CH, Kjaer SK, Hjorth S, Nörby U, Pottegård A, Mathiasen R, et al. Maternal hormonal contraceptive use and childhood central nervous system tumor risk in a large Scandinavian cohort. International Journal of Cancer. 2025. doi:10.1002/ijc.35509

BibTeX
@article{Hemmingsen2025,
  author = {Hemmingsen, Caroline H and Kjaer, Susanne K and Hjorth, Sarah and Nörby, Ulrika and Pottegård, Anton and Mathiasen, René and Skovlund, Charlotte Wessel and Leinonen, Maarit K and Nordeng, Hedvig and Mørch, Lina S and Hargreave, Marie},
  title = {Maternal hormonal contraceptive use and childhood central nervous system tumor risk in a large Scandinavian cohort},
  journal = {International Journal of Cancer},
  year = {2025},
  doi = {10.1002/ijc.35509}
}
Kostenlos starten →